Cas 1173791-19-9,5-hydroxy-3-(4-methoxyphenyl)-7-[3-methyl-3-(3,6-dimethyl-1,4-benzoquinon-2-yl)butan-1-oyloxy]chromen-4-one

1173791-19-9

Post Buying Request

Basic information

Product Name: 5-hydroxy-3-(4-methoxyphenyl)-7-[3-methyl-3-(3,6-dimethyl-1,4-benzoquinon-2-yl)butan-1-oyloxy]chromen-4-one
Synonyms: 5-hydroxy-3-(4-methoxyphenyl)-7-[3-methyl-3-(3,6-dimethyl-1,4-benzoquinon-2-yl)butan-1-oyloxy]chromen-4-one
CAS NO:1173791-19-9
Molecular Formula:
Molecular Weight: 502.521
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 5-hydroxy-3-(4-methoxyphenyl)-7-[3-methyl-3-(3,6-dimethyl-1,4-benzoquinon-2-yl)butan-1-oyloxy]chromen-4-one(CAS DataBase Reference)
NIST Chemistry Reference: 5-hydroxy-3-(4-methoxyphenyl)-7-[3-methyl-3-(3,6-dimethyl-1,4-benzoquinon-2-yl)butan-1-oyloxy]chromen-4-one(1173791-19-9)
EPA Substance Registry System: 5-hydroxy-3-(4-methoxyphenyl)-7-[3-methyl-3-(3,6-dimethyl-1,4-benzoquinon-2-yl)butan-1-oyloxy]chromen-4-one(1173791-19-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1173791-19-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1173791-19-9 Suppliers

Recommended suppliers

1173791-19-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1173791-19-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,7,3,7,9 and 1 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1173791-19:
(9*1)+(8*1)+(7*7)+(6*3)+(5*7)+(4*9)+(3*1)+(2*1)+(1*9)=169
169 % 10 = 9
So 1173791-19-9 is a valid CAS Registry Number.

1173791-19-9Upstream product

1173791-19-9Downstream Products

1173791-19-9Relevant academic research and scientific papers

Synthesis of potential prodrug systems for reductive activation. Prodrugs for anti-angiogenic isoflavones and VEGF receptor tyrosine kinase inhibitory oxindoles

Blanche, Emilie A.,Maskell, Lesley,Colucci, Marie A.,Whatmore, Jacqueline L.,Moody, Christopher J.

experimental part, p. 4894 - 4903 (2009/11/30)

A number of potential prodrug systems for reductive activation have been investigated. The prodrug systems chosen for the study were the 2-nitrophenylacetyl, 3-methyl-3-(3,6-dimethyl-1,4-benzoquinon-2-yl)butanoyl and 4-nitrobenzyl groups, readily attached

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1173791-19-9